A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Pilot Study of Acalabrutinib in Relapsed/Refractory Primary and Secondary CNS Lymphomas	primary central nervous system lymphoma	Active, not recruiting	Phase 2	2026-06-10		NCT04548648

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
AstraZeneca	806
UNC Lineberger Comprehensive Cancer Center	125

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Lineberger Comprehensive Cancer Center	Chapel Hill	United States	15
Moffit Cancer Center	Tampa	United States	20
Wake Forest University,The Atrium Health Wake Forest Baptist Comprehensive Cancer Center	Winston-Salem	United States	1

Clinical trials